(Q41450863)

30 September 2017

1 reference

title

Prostate-specific antigen as a screening test for prostate cancer. The United States experience (English)

1 reference

30 September 2017

Arcangeli CG

1

1 reference

30 September 2017

Ornstein DK

series ordinal

2

1 reference

30 September 2017

Keetch DW

series ordinal

3

1 reference

30 September 2017

Andriole GL

series ordinal

4

1 reference

30 September 2017

1 May 1997

1 reference

Urologic Clinics of North America

30 September 2017

1 reference

30 September 2017

24

1 reference

30 September 2017

2

1 reference

30 September 2017

299-306

1 reference

Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

A guide to the interpretation of serum prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Assessment of screening for prostate cancer using the digital rectal examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The effect of finasteride on prostate specific antigen: review of available data

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Systematic sextant biopsies in 651 patients referred for prostate evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Effect of digital rectal examination (and ejaculation) on serum prostate-specific antigen after twenty-four hours. A randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The pathological features and prognosis of prostate cancer detectable with current diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The impact of ejaculation on serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

The nature of prostate cancer detected through prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Adenocarcinoma of the prostate: results of routine urological screening

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

Ejaculation increases the serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970376-1

7 January 2021

10.1016/S0094-0143(05)70376-1

Identifiers

DOI

1 reference

30 September 2017

1 reference